Page last updated: 2024-10-27
fluphenazine and ALS - Amyotrophic Lateral Sclerosis
fluphenazine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Barmada, SJ | 1 |
| Serio, A | 1 |
| Arjun, A | 1 |
| Bilican, B | 1 |
| Daub, A | 1 |
| Ando, DM | 1 |
| Tsvetkov, A | 1 |
| Pleiss, M | 1 |
| Li, X | 1 |
| Peisach, D | 1 |
| Shaw, C | 1 |
| Chandran, S | 1 |
| Finkbeiner, S | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Rapamycin (Sirolimus) Treatment for Amyotrophic Lateral Sclerosis[NCT03359538] | Phase 2 | 63 participants (Actual) | Interventional | 2017-09-19 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for fluphenazine and ALS - Amyotrophic Lateral Sclerosis